Literature DB >> 2435814

Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity.

M Danner, T A Luger.   

Abstract

Keratinocytes are capable of releasing distinct immunomodulating cytokines such as epidermal cell-derived thymocyte activating factor (ETAF) and an epidermal cell-derived natural killer cell augmenting factor (ENKAF). The present study was performed to determine whether human keratinocytes also may secrete an interleukin 3 (IL-3)-like mediator and thereby participate in the regulation of mast cell activity in the skin. Supernatants of freshly isolated human epidermal cells (EC) and malignant keratinocyte cell lines (A 431, SCC) were tested for their capacity to induce the proliferation of IL-3-dependent cell lines 32 DCL and FDCP. Human epidermal cell interleukin 3 (EC IL-3) is spontaneously released by freshly isolated EC, A 431, and squamous cell carcinoma (SCC) cells. However, both normal EC and A 431 cells produced increased levels of EC IL-3 activity when cultured in the presence of different stimulants, such as phorbol myristate acetate and lipopolysaccharide. The EC IL-3 activity was not inhibited when treated with a monoclonal anti-IL-1 or anti-IL-2-antibody. Biochemical characterization showed that human EC IL-3 has a molecular weight of 17K, elutes of DEAE-ion exchange high-performance liquid chromatography (HPLC) as one major peak at 0.36 M NaCl, and upon HPLC-chromatofocusing exhibits 3 isoelectric points of 7.8, 7.5, and 5.6. Upon reversed-phase HPLC, EC IL-3 activity eluted at about 100% acetonitrile. When highly purified EC IL-3 was labeled with 125I and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, a single homogeneous band exhibiting a molecular weight of 17K was seen, which correlated with the IL-3 activity and was free of ETAF/IL-1, IL-2, and interferon activity. These data indicate that human EC synthesize an IL-3-like cytokine which is distinct from ETAF/IL-1, IL-2, and interferon and thereby may participate in the regulation of mast cell activity during inflammatory and fibrotic, as well as hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435814     DOI: 10.1111/1523-1747.ep12469013

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Contact dermatitis. Clinical perspectives and basic mechanisms.

Authors:  A Nasir; A A Gaspari
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

2.  Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.

Authors:  T S Kupper; F Lee; N Birchall; S Clark; S Dower
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Granulocyte-activating mediators (GRAM). II. Generation by human epidermal cells--relation to GM-CSF.

Authors:  A Kapp; M Danner; T A Luger; C Hauser; E Schöpf
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte-activating factor: implications for skin aging.

Authors:  D N Sauder; B M Stanulis-Praeger; B A Gilchrest
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

5.  Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23.

Authors:  A H Dalloul; M Arock; C Fourcade; J Y Béranger; P Jaffray; P Debré; M D Mossalayi
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  New human oral squamous carcinoma cell line and its tumorigenic subline producing granulocyte colony-stimulating factor.

Authors:  K Matsuo; Y Ishibashi; I Kobayashi; S Ozeki; M Ohishi; T Tange; J Hirata; T Kiyoshima; H Sakai
Journal:  Jpn J Cancer Res       Date:  1994-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.